Table 2: Predictors of stress tests within 2 years after PCI
Group; % of patients*
CharacteristicStress test
n = 83 636
No stress test
n = 44 744
OR (95% CI)†
Demographic
Age, yr, mean ± SD60.7 ± 11.267.6 ± 12.70.958 (0.957-0.959)
Sex, male74.964.31.22 (1.19-1.26)
Residence, rural14.116.40.84 (0.81-0.87)
Site of PCI, teaching hospital61.375.90.52 (0.50-0.53)
Income quintile
    1 (lowest)18.622.81.00 (ref)
    220.021.51.29 (1.08-1.17)
    320.119.51.20 (1.15-1.27)
    420.818.61.26 (1.21-1.32)
    5 (highest)20.317.31.37 (1.32-1.43)
Procedure yearNA0.96 (0.96-0.97)
Canadian Cardiovascular Society angina classification
05.66.51.00 (ref)
14.73.91.22 (1.12-1.32)
214.311.91.26 (1.19-1.35)
312.612.81.05 (0.98-1.11)
≥ 460.762.80.97 (0.92-1.02)
Cardiac risk factors and comorbidities
Diabetes mellitus27.736.30.83 (0.80-0.85)
Hypertension69.679.00.95 (0.91-0.98)
Hyperlipidemia62.864.01.15 (1.12-1.18)
Myocardial infarction48.955.00.86 (0.83-0.88)
Heart failure3.711.80.57 (0.54-0.60)
History of stroke1.12.70.78 (0.71-0.86)
Peripheral vascular disease4.18.90.75 (0.71-0.79)
Renal failure1.85.50.79 (0.72-0.85)
Chronic obstructive pulmonary disease4.910.50.76 (0.72-0.80)
Smoking history53.251.10.89 (0.87-0.92)
Charlson comorbidity index, mean ± SD0.47 ± 1.050.90 ± 1.580.94 (0.93-0.95)
PCI characteristics
Stent type
    Drug-eluting43.839.01.00 (ref)
    Bare metal59.759.90.87 (0.84-0.89)
No. of stented vessels
    146.748.01.00 (ref)
    249.444.31.01 (0.98-1.05)
     33.97.71.00 (0.96-1.05)
Stent diameter, mm
     < 346.748.01.00 (ref)
      349.444.31.05 (1.02-1.08)
Total stent length, mm
     < 2034.833.21.00 (ref)
      2061.259.11.00 (0.96-1.03)

Note: CI = confidence interval, NA = not applicable, OR = odds ratio, PCI = percutaneous coronary intervention, SD = standard deviation.

*Except where indicated otherwise.

†Adjusted for demographic factors (age, sex, income, rural residence), cardiac risk factors (diabetes mellitus, hypertension, dyslipidemia, smoking), angina classification, comorbidities (myocardial infarction, heart failure, peripheral vascular disease, cerebrovascular disease, renal failure, chronic obstructive pulmonary disease), PCI characteristics (stent type, size, length) and teaching hospital status.